208 related articles for article (PubMed ID: 19082485)
21. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
22. Curcumin inhibits WT1 gene expression in human leukemic K562 cells.
Anuchapreeda S; Thanarattanakorn P; Sittipreechacharn S; Chanarat P; Limtrakul P
Acta Pharmacol Sin; 2006 Mar; 27(3):360-6. PubMed ID: 16490174
[TBL] [Abstract][Full Text] [Related]
23. Cyclin A is essential for the p53-modulated inhibition from benzo(a)pyrene toxicity in A549 cells.
Wang Z; Qi Y; Chen Q; Yang D; Tang S; Jin X; Gao J; Fu J; Zhou Z; Wang J; Xiao X
Toxicology; 2009 Feb; 256(1-2):1-6. PubMed ID: 19027820
[TBL] [Abstract][Full Text] [Related]
24. Effect of WT1 gene expression on cell growth and proliferation in myeloid leukemia cell lines.
Mi Y; Wang L; Bian S; Meng Q; Chen G; Wang J
Chin Med J (Engl); 1999 Aug; 112(8):705-8. PubMed ID: 11601276
[TBL] [Abstract][Full Text] [Related]
25. WT1 protein expression in slowly proliferating myeloid leukemic cell lines is scarce throughout the cell cycle with a minimum in G0/G1 phase.
Kerst G; Bergold N; Viebahn S; Gieseke F; Kalinova M; Trka J; Handgretinger R; Müller I
Leuk Res; 2008 Sep; 32(9):1393-9. PubMed ID: 18457871
[TBL] [Abstract][Full Text] [Related]
26. DNA-binding dependent and independent functions of WT1 protein during human hematopoiesis.
Svensson E; Eriksson H; Gekas C; Olofsson T; Richter J; Gullberg U
Exp Cell Res; 2005 Aug; 308(1):211-21. PubMed ID: 15907324
[TBL] [Abstract][Full Text] [Related]
27. N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation.
Shen S; Passioura T; Symonds G; Dolnikov A
Exp Hematol; 2007 Jun; 35(6):908-19. PubMed ID: 17533045
[TBL] [Abstract][Full Text] [Related]
28. WT1-mediated gene regulation in early urogenital ridge development.
Klattig J; Sierig R; Kruspe D; Makki MS; Englert C
Sex Dev; 2007; 1(4):238-54. PubMed ID: 18391535
[TBL] [Abstract][Full Text] [Related]
29. High WT1 expression is associated with very poor survival of patients with osteogenic sarcoma metastasis.
Srivastava A; Fuchs B; Zhang K; Ruan M; Halder C; Mahlum E; Weber K; Bolander ME; Sarkar G
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4237-43. PubMed ID: 16857797
[TBL] [Abstract][Full Text] [Related]
30. Role of the Wilms' tumor 1 gene in the aberrant biological behavior of leukemic cells and the related mechanisms.
Li Y; Wang J; Li X; Jia Y; Huai L; He K; Yu P; Wang M; Xing H; Rao Q; Tian Z; Tang K; Wang J; Mi Y
Oncol Rep; 2014 Dec; 32(6):2680-6. PubMed ID: 25310451
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of N-Myc rapidly causes acute myeloid leukemia in mice.
Kawagoe H; Kandilci A; Kranenburg TA; Grosveld GC
Cancer Res; 2007 Nov; 67(22):10677-85. PubMed ID: 18006809
[TBL] [Abstract][Full Text] [Related]
32. Wt1 is not essential for hematopoiesis in the mouse.
King-Underwood L; Little S; Baker M; Clutterbuck R; Delassus S; Enver T; Lebozer C; Min T; Moore A; Schedl A; Pritchard-Jones K
Leuk Res; 2005 Jul; 29(7):803-12. PubMed ID: 15927676
[TBL] [Abstract][Full Text] [Related]
33. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells.
Glienke W; Maute L; Wicht J; Bergmann L
Eur J Cancer; 2009 Mar; 45(5):874-80. PubMed ID: 19196508
[TBL] [Abstract][Full Text] [Related]
34. Cyclin A1 expression and associations with disease characteristics in childhood acute lymphoblastic leukemia.
Holm C; Ora I; Brunhoff C; Anagnostaki L; Landberg G; Persson JL
Leuk Res; 2006 Mar; 30(3):254-61. PubMed ID: 16182364
[TBL] [Abstract][Full Text] [Related]
35. An isoform of the Wilms' tumor suppressor gene potentiates granulocytic differentiation.
Loeb DM; Summers JL; Burwell EA; Korz D; Friedman AD; Sukumar S
Leukemia; 2003 May; 17(5):965-71. PubMed ID: 12750711
[TBL] [Abstract][Full Text] [Related]
36. WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?
Bader P; Niemeyer C; Weber G; Coliva T; Rossi V; Kreyenberg H; Gerecke A; Biondi A
Eur J Haematol; 2004 Jul; 73(1):25-8. PubMed ID: 15182334
[TBL] [Abstract][Full Text] [Related]
37. A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer.
Wegiel B; Bjartell A; Ekberg J; Gadaleanu V; Brunhoff C; Persson JL
Oncogene; 2005 Sep; 24(42):6385-93. PubMed ID: 16007189
[TBL] [Abstract][Full Text] [Related]
38. Truncation of WT1 results in downregulation of cyclin G1 and IGFBP-4 expression.
Wagner KJ; Patek CE; Miles C; Christie S; Brookes AJ; Hooper ML
Biochem Biophys Res Commun; 2001 Oct; 287(4):977-82. PubMed ID: 11573961
[TBL] [Abstract][Full Text] [Related]
39. Wilms' tumor gene 1 (WT1) expression in subtypes of acute lymphoblastic leukemia (ALL) of adults and impact on clinical outcome.
Busse A; Gökbuget N; Siehl JM; Hoelzer D; Schwartz S; Rietz A; Thiel E; Keilholz U
Ann Hematol; 2009 Dec; 88(12):1199-205. PubMed ID: 19404640
[TBL] [Abstract][Full Text] [Related]
40. miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia.
Pigazzi M; Manara E; Baron E; Basso G
Cancer Res; 2009 Mar; 69(6):2471-8. PubMed ID: 19258499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]